Kidney Disease Market to Reach $149.44 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Kidney Disease Market?
In recent times, the market size for kidney disease has seen robust growth. There will be a rise from $107.29 billion in 2024 to $114.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. Factors such as escalating chronic health conditions, an aging populace, genetic susceptibility, advancements in medical research and education, coupled with environmental variables have contributed to the growth during the historic period.
What Growth Rate Is Forecasted for the Kidney Disease Market by 2029?
The market for kidney disease is anticipated to experience significant expansion in the coming years, with a projected value of $149.44 billion in 2029 and a compound annual growth rate (CAGR) of 6.8%. This projected growth during the forecast period is believed to be driven by factors such as worldwide management of infectious diseases, precision medical treatments, an uptick in diabetes and obesity, healthcare policy shifts, and advancement in awareness and screening. Key trends during this period are expected to include the adoption of telemedicine for kidney health, a focus on preventive nephrology, the emergence of at-home dialysis, the progression of regenerative therapies, and changes in diet and nutrition.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp
Which Key Companies Are Shaping the Future of the Kidney Disease Market?
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.
Which Factors Are Driving Demand in the Kidney Disease Industry?
The surge in kidney-related ailments is predicted to boost the kidney disease market’s expansion. The term “kidney diseases” encompasses various conditions that impair the kidneys’ functioning and structure. Medications for kidney conditions serve to decrease blood pressure in patients, limit protein loss, slow kidney damage progression, manage symptoms, and ward off complications. For instance, in June 2023, Kidney Research UK, a UK-based charitable organization dedicated to research and advocacy in kidney diseases, disclosed that approximately 7.19 million individuals in the UK suffered from chronic kidney disease in 2023, equating to over 10% of the UK population. This figure is forecasted to rise to 7.61 million individuals by 2033. Hence, the escalating prevalence of kidney diseases is fueling the growth of the kidney disease market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp
How Is the Kidney Disease Market Segmented by Several Divisions?
The kidney disease market covered in this report is segmented –
1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care
What are the Emerging Market Trends Driving the Growth of the Kidney Disease Industry?
The adoption of AI-based tools in the kidney disease market is a prominent trend gaining traction. Businesses in this sector are embracing innovative technologies to enhance patient results and maintain their market standing. For example, Carenostics, a healthcare startup from the US that specializes in AI solutions, unveiled its premiere product in November 2022. This product is engineered to sift through electronic health record (EHR) data to detect early signs of chronic kidney disease (CKD). The company’s integration of AI-backed clinical decision support models into healthcare providers’ EHR systems allows doctors to pinpoint patients at high risk for chronic illnesses, thus facilitating early intervention for better patient outcomes.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report
Which Regions Are Driving Growth in the Kidney Disease Market?
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938
This Report Delivers Insight On:
1. How big is the kidney disease market, and how is it changing globally?
2. Who are the major companies in the kidney disease market, and how are they performing?
3. What are the key opportunities and risks in the kidney disease market right now?
4. Which products or customer segments are growing the most in the kidney disease market?
5. What factors are helping or slowing down the growth of the kidney disease market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model